nodes	percent_of_prediction	percent_of_DWPC	metapath
Secobarbital—Hypoxia—Fludarabine—lymphatic system cancer	0.0553	0.0553	CcSEcCtD
Secobarbital—Anaemia megaloblastic—Methotrexate—lymphatic system cancer	0.0442	0.0442	CcSEcCtD
Secobarbital—Respiratory failure—Fludarabine—lymphatic system cancer	0.0358	0.0358	CcSEcCtD
Secobarbital—Thinking abnormal—Carmustine—lymphatic system cancer	0.0245	0.0245	CcSEcCtD
Secobarbital—Injection site reaction—Carmustine—lymphatic system cancer	0.0223	0.0223	CcSEcCtD
Secobarbital—Respiratory failure—Vincristine—lymphatic system cancer	0.0218	0.0218	CcSEcCtD
Secobarbital—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.0217	0.0217	CcSEcCtD
Secobarbital—Mental disability—Carmustine—lymphatic system cancer	0.0195	0.0195	CcSEcCtD
Secobarbital—Hypoxia—Methotrexate—lymphatic system cancer	0.0164	0.0164	CcSEcCtD
Secobarbital—Agitation—Teniposide—lymphatic system cancer	0.016	0.016	CcSEcCtD
Secobarbital—Ataxia—Carmustine—lymphatic system cancer	0.0153	0.0153	CcSEcCtD
Secobarbital—Ataxia—Vincristine—lymphatic system cancer	0.0146	0.0146	CcSEcCtD
Secobarbital—Confusional state—Teniposide—lymphatic system cancer	0.0144	0.0144	CcSEcCtD
Secobarbital—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Secobarbital—Agitation—Fludarabine—lymphatic system cancer	0.0141	0.0141	CcSEcCtD
Secobarbital—Hypotension—Teniposide—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Secobarbital—Confusional state—Fludarabine—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Secobarbital—Vomiting—Mechlorethamine—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Secobarbital—Apnoea—Methotrexate—lymphatic system cancer	0.0123	0.0123	CcSEcCtD
Secobarbital—Rash—Mechlorethamine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Secobarbital—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0122	0.0122	CcSEcCtD
Secobarbital—Feeling abnormal—Teniposide—lymphatic system cancer	0.0117	0.0117	CcSEcCtD
Secobarbital—Nausea—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Secobarbital—Body temperature increased—Teniposide—lymphatic system cancer	0.0113	0.0113	CcSEcCtD
Secobarbital—Hallucination—Carmustine—lymphatic system cancer	0.0112	0.0112	CcSEcCtD
Secobarbital—Hallucination—Vincristine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Secobarbital—Constipation—Fludarabine—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Secobarbital—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0107	0.0107	CcSEcCtD
Secobarbital—Respiratory failure—Methotrexate—lymphatic system cancer	0.0106	0.0106	CcSEcCtD
Secobarbital—Hypersensitivity—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Secobarbital—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0103	0.0103	CcSEcCtD
Secobarbital—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.01	0.01	CcSEcCtD
Secobarbital—Body temperature increased—Fludarabine—lymphatic system cancer	0.0099	0.0099	CcSEcCtD
Secobarbital—Confusional state—Bleomycin—lymphatic system cancer	0.00926	0.00926	CcSEcCtD
Secobarbital—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00923	0.00923	CcSEcCtD
Secobarbital—Vomiting—Teniposide—lymphatic system cancer	0.00906	0.00906	CcSEcCtD
Secobarbital—Agitation—Carmustine—lymphatic system cancer	0.00903	0.00903	CcSEcCtD
Secobarbital—Rash—Teniposide—lymphatic system cancer	0.00899	0.00899	CcSEcCtD
Secobarbital—Dermatitis—Teniposide—lymphatic system cancer	0.00898	0.00898	CcSEcCtD
Secobarbital—Headache—Teniposide—lymphatic system cancer	0.00893	0.00893	CcSEcCtD
Secobarbital—Agitation—Vincristine—lymphatic system cancer	0.00862	0.00862	CcSEcCtD
Secobarbital—Hypotension—Bleomycin—lymphatic system cancer	0.00858	0.00858	CcSEcCtD
Secobarbital—Nausea—Teniposide—lymphatic system cancer	0.00847	0.00847	CcSEcCtD
Secobarbital—Anxiety—Carmustine—lymphatic system cancer	0.00833	0.00833	CcSEcCtD
Secobarbital—Confusional state—Carmustine—lymphatic system cancer	0.00808	0.00808	CcSEcCtD
Secobarbital—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00801	0.00801	CcSEcCtD
Secobarbital—Vomiting—Fludarabine—lymphatic system cancer	0.00796	0.00796	CcSEcCtD
Secobarbital—Rash—Fludarabine—lymphatic system cancer	0.0079	0.0079	CcSEcCtD
Secobarbital—Dermatitis—Fludarabine—lymphatic system cancer	0.00789	0.00789	CcSEcCtD
Secobarbital—Headache—Fludarabine—lymphatic system cancer	0.00785	0.00785	CcSEcCtD
Secobarbital—Anxiety—Mitoxantrone—lymphatic system cancer	0.00775	0.00775	CcSEcCtD
Secobarbital—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00757	0.00757	CcSEcCtD
Secobarbital—Confusional state—Mitoxantrone—lymphatic system cancer	0.00751	0.00751	CcSEcCtD
Secobarbital—Hypotension—Carmustine—lymphatic system cancer	0.00749	0.00749	CcSEcCtD
Secobarbital—Nausea—Fludarabine—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Secobarbital—Shock—Mitoxantrone—lymphatic system cancer	0.00733	0.00733	CcSEcCtD
Secobarbital—Body temperature increased—Bleomycin—lymphatic system cancer	0.00726	0.00726	CcSEcCtD
Secobarbital—Hypotension—Vincristine—lymphatic system cancer	0.00715	0.00715	CcSEcCtD
Secobarbital—Somnolence—Carmustine—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Secobarbital—Ataxia—Methotrexate—lymphatic system cancer	0.0071	0.0071	CcSEcCtD
Secobarbital—Hypotension—Mitoxantrone—lymphatic system cancer	0.00696	0.00696	CcSEcCtD
Secobarbital—Constipation—Carmustine—lymphatic system cancer	0.00686	0.00686	CcSEcCtD
Secobarbital—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00677	0.00677	CcSEcCtD
Secobarbital—Somnolence—Mitoxantrone—lymphatic system cancer	0.00663	0.00663	CcSEcCtD
Secobarbital—Feeling abnormal—Carmustine—lymphatic system cancer	0.00661	0.00661	CcSEcCtD
Secobarbital—Constipation—Vincristine—lymphatic system cancer	0.00654	0.00654	CcSEcCtD
Secobarbital—Constipation—Mitoxantrone—lymphatic system cancer	0.00637	0.00637	CcSEcCtD
Secobarbital—Body temperature increased—Carmustine—lymphatic system cancer	0.00634	0.00634	CcSEcCtD
Secobarbital—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00614	0.00614	CcSEcCtD
Secobarbital—Body temperature increased—Vincristine—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Secobarbital—Hypersensitivity—Carmustine—lymphatic system cancer	0.00591	0.00591	CcSEcCtD
Secobarbital—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Secobarbital—Vomiting—Bleomycin—lymphatic system cancer	0.00584	0.00584	CcSEcCtD
Secobarbital—Rash—Bleomycin—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Secobarbital—Dermatitis—Bleomycin—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Secobarbital—Hypersensitivity—Vincristine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Secobarbital—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Secobarbital—Nausea—Bleomycin—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Secobarbital—Dizziness—Carmustine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Secobarbital—Vomiting—Carmustine—lymphatic system cancer	0.0051	0.0051	CcSEcCtD
Secobarbital—Dizziness—Vincristine—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Secobarbital—Rash—Carmustine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Secobarbital—Dermatitis—Carmustine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Secobarbital—Headache—Carmustine—lymphatic system cancer	0.00502	0.00502	CcSEcCtD
Secobarbital—Vomiting—Vincristine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Secobarbital—Rash—Vincristine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Secobarbital—Dermatitis—Vincristine—lymphatic system cancer	0.00482	0.00482	CcSEcCtD
Secobarbital—Headache—Vincristine—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Secobarbital—Nausea—Carmustine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Secobarbital—Vomiting—Mitoxantrone—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Secobarbital—Rash—Mitoxantrone—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Secobarbital—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Secobarbital—Headache—Mitoxantrone—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Secobarbital—Nausea—Vincristine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Secobarbital—Nausea—Mitoxantrone—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Secobarbital—Confusional state—Methotrexate—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Secobarbital—Hypotension—Methotrexate—lymphatic system cancer	0.00347	0.00347	CcSEcCtD
Secobarbital—Somnolence—Methotrexate—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Secobarbital—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Secobarbital—Body temperature increased—Methotrexate—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Secobarbital—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Secobarbital—Dizziness—Methotrexate—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Secobarbital—Vomiting—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Secobarbital—Rash—Methotrexate—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Secobarbital—Dermatitis—Methotrexate—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Secobarbital—Headache—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Secobarbital—Nausea—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
